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Chronic conditions are the most common problems in health care and the leading causes of death globally.1 Acute communicable diseases have given way to 
chronic conditions such as arthritis, diabetes, and cardiovas-
cular and respiratory diseases that will impose an even 
greater burden in the future.2 The needs of patients with 
these diseases are usually complex and are challenging to 
manage. For this reason, many chronic disease prevention 
and management (CDPM) programs have been designed 
with the aim of improving outcomes in these patients. 
CDPM programs targeting diabetes,3–7 asthma,8,9 heart dis-
eases,10–12 depression,13–15 chronic obstructive lung disease 
(COPD),16,17 obesity,18,19 kidney disease,20 dyslipidemia,21 
hypertension22 and chronic pain23 have been shown to be 
effective in improving outcomes such as hospital admissions, 
costs, adherence to medication, disease control, use of health 
services, quality of life and mortality. However, these studies 
were conducted in different settings and were based on sin-
gle diseases.
Interventions oriented toward single diseases take little 
account of the multiple morbidities experienced by most 
patients in primary care. To date, the appropriateness of using 
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Background: Chronic disease prevention and management programs are usually single-disease oriented. Our objective was to eval-
uate an intervention that targeted multiple chronic conditions and risk factors.
Methods: We conducted a pragmatic randomized controlled trial involving patients aged 18–75 years with at least 1 of the targeted 
chronic conditions or risk factors from 8 primary care practices in the Saguenay region of Quebec, Canada, to evaluate an interven-
tion that included self-management support and patient-centred motivational approaches. Self-management (primary outcome) was 
evaluated using the Health Education Impact Questionnaire (heiQ). Secondary outcomes included self-efficacy, health-related quality 
of life, psychological distress and health behaviours.
Results: Three hundred thirty-two patients were recruited and randomly assigned (n = 166 for both intervention and control groups) 
and evaluated after 3 months. The intervention group showed improvement in 6 of the 8 heiQ domains: health-directed behaviour 
(relative risk [RR] 1.71, 95% confidence interval [CI] 1.13 to 2.59), emotional well-being (RR 1.73, 95% CI 1.07 to 2.79), self-monitor-
ing and insight (RR 2.40, 95% CI 1.19 to 4.86), constructive attitudes and approaches (RR 2.40, 95% CI 1.37 to 4.21), skill and tech-
nique acquisition (RR 1.70, 95% CI 1.14 to 2.53), and health service navigation (RR 1.93, 95% CI 1.08 to 3.47). Improvement was 
also observed in the Physical Component Summary (p = 0.017) and the Single Index (p = 0.041) of the 12-Item Short Form Health 
Survey (version 2). The intervention group improved in fruit and vegetable consumption (odds ratio [OR] 2.36, 95% CI 1.41 to 3.95) 
and physical activity (OR 3.81, 95% CI 1.65 to 8.76). One-year improvement was maintained in the intervention group for several 
outcomes.
Interpretation: It is possible to implement an intervention integrating chronic disease prevention and management services into pri-
mary care settings. We obtained positive and promising results using this intervention. Trial registration: ClinicalTrials.gov, 
no.: NCT01319656.
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multidisciplinary professionals in the context of CDPM pro-
grams addressing several conditions has been scarcely studied; 
however, a few studies have reported mixed but promising 
results.24–26
We introduce a pragmatic innovation involving the adap-
tation and integration of CDPM services for multiple diseases 
into the primary care setting and propose an innovative com-
bination of strategies to evaluate the effects and the imple-
mentation of this intervention in primary care practices. We 
wanted to test whether it was possible to implement an inter-
vention integrating multiple disease-oriented CDPM services 
into the primary care setting. We hypothesized that patients 
receiving the intervention would report better self-manage-
ment, empowerment and self-efficacy and would show 
reduced health-risk behaviours.27
Methods
Settings
We conducted our study (Adaptation, implantation et évalua-
tion d’une intervention d’intégration des services de réadapta-
tion en maladies chroniques aux soins de 1re ligne [Adapting 
and integrating chronic disease prevention and management 
services into primary care settings], PR1MaC) in 8 primary 
care practices in the Saguenay region of Quebec, Canada. Pri-
mary care physicians in Quebec mainly work in 2 types of 
organizations: Group practices (involving a group of primary 
care physicians working in a team) and Family Medicine 
Groups (new organizations in which primary care physicians 
work with nurses in various degrees of collaboration and share 
the same patients and medical files). Four Family Medicine 
Groups and 4 solo practices were selected based on geo-
graphic localization in the same region and on the population 
of patients they are serving. The purpose was to ensure a cer-
tain level of variation in the cohort.
Participants
Patients were referred to the research team by their primary 
care providers to assess eligibility, obtain informed consent 
and receive the intervention. Patients had to be between 18 
and 75 years of age and present with at least 1 of the following 
chronic conditions or risk factors: diabetes, cardiovascular dis-
ease, COPD, asthma, tobacco smoking, obesity, hyperlipid-
emia, prediabetes, sedentary lifestyle or any combination of 
these. Patients were required to be fluent in written and spo-
ken French. All study documents and tools, including ques-
tionnaires and interview guides, were developed in French.
Intervention
Detailed information on the intervention has been published 
elsewhere27 and is also provided in Appendix 1 (available at 
www.cmajopen.ca/content/4/4/E588/suppl/DC1). The prin-
ciples guiding the intervention were based on self-manage-
ment support and health education, a patient-centred 
approach, motivational approach and interprofessional col-
laboration. For each patient, the intervention started with a 
preliminary clinical evaluation by a trained nurse. The nurse 
then designed an individualized intervention plan in collabo-
ration with the patient that could include encounters with 1 
or more CDPM professionals in the following disciplines: 
nursing, physical activity, nutrition, respiratory therapy and 
smoking cessation therapy. The intervention plan was based 
on the patient’s objectives as identified at the first encounter 
but could be further adapted by any professional in each dis-
cipline involved. Fidelity to the processes was ensured by reg-
ular contact with the CDPM professionals. Each intervention 
was supported by printed information and other educational 
material to help maintain patient engagement between visits. 
Intervention at the patient level was individualized and edu-
cational in nature, was given over a 3-month period at the 
most and consisted of at least 3 individual encounters with 
trained CDPM professionals. Interventions were done by 
CDPM professionals who were recruited and trained by the 
research team and travelled from 1 organization to the other 
to deliver the services.
Study design
The effectiveness of this pragmatic intervention was assessed 
using a combination of 3 experimental designs.
Pragmatic randomized trial
Participants reported sociodemographic data and completed 
an initial set of questionnaires at baseline. Patients were then 
randomly assigned to receive an immediate (intervention 
group, group A) or delayed intervention (control group, 
group B) that occurred 3 months after baseline. To prevent 
selection bias, a rigorous randomization process with alloca-
tion concealment was followed. To generate a random alloca-
tion sequence, 2 people unrelated to the study prepared sealed 
and unmarked opaque envelopes containing cards with either 
a letter A (intervention) or B (control) in equal numbers. 
Envelopes were shuffled several times to generate a random 
sequence of assignments. A research assistant was responsible 
for the random group assignment of patients. To prevent sub-
version of the allocation sequence, every time the research 
assistant received a baseline questionnaire completed by mail, 
he called the patient, opened 1 envelope to notify the patient 
of their allocation to a group, and wrote the information in 
the patient’s file. Blinding was not achievable, because both 
patients and health care providers knew who was involved in 
each group.
Three months after baseline, patients in both groups com-
pleted a second evaluation (Figure 1).
Before-and-after design
To document the effectiveness of the intervention at 1 year, 
patients in the intervention group were reassessed a third time 
using the same measurement tools (Figure 1).
Controlled before-and-after design
We also used a controlled before-and-after design with a 
comparative cohort used to evaluate 1-year effectiveness. All 
patients who received the intervention (immediate and 
delayed) were included in this analysis. The control cohort 
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(group C) was from the Program of Research on the Evolu-
tion of a Cohort Investigating Health System Effects (PRE-
CISE) research program.28 The PRECISE program recruited 
a cohort of adults aged 25–75 years who were followed for 
4 years with no intervention. The target population was com-
munity-dwelling adults undifferentiated by disease, who did 
not have any major cognitive impairment and were able to 
respond to written and oral questions in English or French. 
Participants were randomly selected from the geographic 
boundaries of 4 regions of Quebec. Patients from this obser-
vational cohort (2198 participants) were pair-matched with all 
patients in our study (intervention and control groups) by age 
(± 5 yr), sex, number of chronic diseases, main diagnosis and 
other diagnoses when possible. Groups were compared on the 
basis of changes over 1 year (Figure 1).
Variables and outcome measures
At baseline, we collected participant sociodemographic data 
including sex, age, education, income, marital status and occu-
pation in French. We also measured the illness burden using 
the Disease Burden Morbidity Assessment tool.29,30
We evaluated the primary outcome, self-management, 
using the Health Education Impact Questionnaire (heiQ),31,32 
which provides a broad profile of the potential impacts of 
patient education interventions and is specifically designed to 
be applied across a large range of chronic conditions. The 
heiQ measures 8 different domains related to self-manage-
ment. Each domain is standardized to range from 1 to 4, and 
baseline and follow-up data are compared to determine the 
achievement of meaningful changes in each domain. The 
questionnaire has high construct validity and good reliabil-
ity.32 The development and validation of the heiQ, including 
the French version, has been described previously.32,33
Secondary outcomes used to assess the effectiveness of the 
intervention were self-efficacy, health-related quality of life, 
psychological distress and lifestyle factors. We evaluated self-
efficacy using the Self-Efficacy for Managing Chronic Disease 
6-Item Scale.34,35
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Figure 1: Flow diagram for the PR1MaC study. PR1MaC = Adaptation, implantation et évaluation d’une intervention d’intégration des 
services de réadaptation en maladies chroniques aux soins de 1re ligne (Adapting and integrating chronic disease prevention and man-
agement services into primary care settings), RCT = randomized controlled trial.
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We measured health-related quality of life (HRQoL) using 
the 12-Item Short-Form Health Survey (SF-12 version 2).36 
The measurement includes the components of physical func-
tioning and mental health. We also calculated a preference-
based single index of quality of life (6-dimensional health state 
classificaton, SF-6D) by applying a scoring method that con-
tains 6 dimensions of the SF-12 (version 2).37 Higher values 
indicate better health status in all measures of HRQoL. 
We assessed psychological distress using the Kessler Psy-
chological Distress Scale (K6).38,39 Scores range from 0 to 24; 
we considered scores of 13 or higher as indicating the pres-
ence of psychological distress. 
Finally, we used 3 self-reported lifestyle indicators: fruit 
and vegetable consumption, physical activity and body mass 
index (BMI) derived from self-reported weight and height. 
The criteria for classifying participants as achieving recom-
mended behavioural targets were the following: consumption 
of 5 portions or more of fruit and vegetables daily (1 portion = 
4 oz or 125 mL), being physically active (20–30 min of exer-
cise 4 times/wk) and normal BMI (18.5–24.9 kg/m2).40 All the 
above outcomes were measured at baseline, after 3 months 
and after 1 year via self-report.
Sample size and statistical power
We calculated the required sample size 326 participants for 
the randomized clinical trial for the main outcome (the per-
centage of patients who improved as measured by the heiQ) 
with a 2-sided α = 0.05 and 80% power, and we accounted for 
a drop out rate of 15%. We estimated that an effect size of 
0.34 would be detectable for continuous scores.
Data analysis
Randomized trial
To evaluate meaningful individual changes in the heiQ 
domains, we used the classical Jacobsen and Truax Reliable 
Change Index, with a cut-off point greater than 1.65.41 To 
determine that a change was meaningful, we corrected each 
individual difference in score on each domain by dividing the 
difference by the standard error (SE) of the difference. If the 
corrected difference exceeded the 1.65 threshold, we consid-
ered this difference meaningful (reliable). The cut-off point of 
greater than 1.65 is equivalent to a probability of 10% of an 
approximately equal balance between errors in the direction 
of classifying a participant as “reliably changed” when the 
observed change was actually because of error, and errors in 
the direction of classifying an individual as “not changed” 
when the observed change was actually reliable. For each of 
the 8 domains of the heiQ, we compared the percentage of 
subjects with a reliable improvement in each group (interven-
tion v. control) using relative risk (RR) with a 95% confidence 
interval (CI). Primary analysis used intention to treat.
To evaluate intervention effects on quantitative outcome, 
we compared the scores of the intervention and control 
groups after 3 months with an analysis of covariance 
(ANCOVA) adjusted for baseline scores.42 Unstandardized 
(differences between means with 95% CI), adjusted and stan-
dardized (Cohen’s effect size d) differences between means are 
also reported. For dichotomous outcomes, we compared 
intervention and control groups using a logistic regression 
analysis adjusted for baseline and report odds ratios (ORs). 
We undertook a complete case analysis because there were 
only a few missing outcomes after 3 months (< 5%).43
Before-and-after design
To test the effectiveness of the intervention within the inter-
vention group over 1 year, we used the paired t test for con-
tinuous variables and the McNemar test for categorical 
variables.
Controlled before-and-after design
For comparisons with group C (PRECISE) over 1 year, we 
used ANCOVA or logistic regression analysis and adjusted for 
scores at baseline.
We used IBM SPSS Statistics 20 for all data analyeses. In 
all statistical tests, we tested for significance at the 5% level. 
Cohen’s d effect size44 was calculated with Microsoft Office 
Excel 2007 using the pooled standard deviation (SD) for the 
samples in the calculation.
This study received ethics approval from the Research 
Ethics Board of the Centre de santé et de services sociaux de 
Chicoutimi.
Results
Figure 1 provides flowchart diagram for the 3 different exper-
imental designs. Table  1 shows the baseline demographics 
and clinical characteristics of participants for each group. 
Among patients in the intervention group, mean time for the 
intervention was 220 (SD  77) minutes and a mean of 2.4 
(SD  1.2) visits with CDPM professionals (range 0–5 visits; 
there were patients who had encounters with more than 1 
CDPM professional).
Randomized trial
The recruitment and follow-up started in November  2011 
and ended in July 2012. A total of 481 eligible patients were 
referred by primary care providers; 144 patients received the 
intervention but refused to participate in the research. All 
patients were contacted to reassess their eligibility, to discuss 
the study and to obtain their informed consent if they agreed 
to participate in the study. Patients who refused to partici-
pate received the intervention offered by their primary care 
provider (Figure  1), but they were not included as partic-
pants. Of the 337 patients who initially agreed to participate, 
5 declined before completing the baseline questionnaires. 
The remaining 332 patients were randomnly assigned (166 
to the intervention group and 166 to the control group). 
The number of participants from each practice ranged from 
9 to 80. Nine patients from the intervention group and 5 
patients from the control group were lost to follow-up after 
3  months. Therefore, 157 patients from the intervention 
group and 161 patients from the control group underwent 
the evaluation after 3 months.
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Scores for heiQ in the intervention and control groups at 
baseline and after 3 months are shown in Table 2. Mean abso-
lute values after 3 months were significantly different from 
baseline in 6 of the 8 domains of heiQ: health-directed behav-
iour, emotional well-being, self-monitoring and insight, con-
structive attitudes and approaches, skill and technique acquisi-
tion, and health service navigation. Figure  2 shows the 
relative risk of a reliable improvement from baseline to 
3 months in the intervention group compared with the con-
trol group for each domain of self-management. Point esti-
mates varied from 1.15 to 2.4, and the lower boundary for 
95% CI was greater than 1 in the same 6 domains of heiQ in 
which mean absolute values were different from baseline after 
3 months. The number of participants used to calculate the 
percentage of patients who had a reliable improvement in 
heiQ score in the 2 groups is shown in Appendix 1.
For the other continuous variables (Self-Efficacy for Man-
aging Chronic Disease, Physical Component Summary of 
SF-12 [version 2], Mental Component Summary of SF-12 
[version 2], Single Index of Sf-12 [version 2] and BMI), differ-
ences in mean scores between the intervention and control 
groups were statistically significant for the Physical Compo-
nent Summary (Appendix 1). Results of the logistic regression 
analysis for the presence of psychological distress, recom-
mended consumption of fruit and vegetables, and recom-
mended physical activity are shown in Table 3. The interven-
tion group had significantly higher ORs for fruit and 
vegetable consumption, and physical activity.
Table 1: Demographic and clinical characteristics of participants at baseline
Characteristic
No. of participants (%)*
Intervention 
group
n = 166
Control group
n = 166
PRECISE 
control cohort†
n = 332
Age, yr; mean ± SD 52.4 ± 11.6 52.6 ± 11.6 54.0 ± 9.9
No. of chronic diseases, mean ± SD 5.1 ± 2.6 4.8 ± 2.2 4.8 ± 2.5
Illness burden (DBMA score); mean ± SD 11.0 ± 7.7 9.6 ± 6.3 9.7 ± 7.5
Male 88 (53.0) 84 (50.6) 174 (52.4)
Multimorbidity (≥ 2 conditions) 159 (95.8) 156 (94.0) 313 (94.3)
Multimorbidity (≥ 3 conditions) 139 (83.7) 142 (85.5) 271 (81.6)
Education level
    Did not complete high school 21 (12.7) 38 (22.9) 78 (23.5)
    High school 58 (34.9) 52 (31.3) 122 (36.7)
    College 48 (28.9) 49 (29.5) 73 (22.0)
    University 37 (22.3) 27 (16.3) 58 (17.5)
    Missing data 2 (1.2) – 1 (0.3)
Household income, Can$
    < 20 000 20 (12.0) 21 (12.7) 50 (15.1)
    20 000–49 999 58 (34.9) 65 (39.2) 132 (39.8)
    ≥ 50 000 84 (50.6) 77 (46.4) 145 (43.7)
    Missing data 4 (2.4) 3 (1.8) 5 (1.5)
Marital status
    Married 114 (68.7) 131 (78.9) 219 (66.0)
    Single or divorced 42 (25.3) 29 (17.4) 98 (29.56)
    Widowed 10 (6.0) 6 (3.6) 15 (4.5)
Employment
    Employed 97 (58.4) 95 (57.2) 167 (50.3)
    Unemployed 23 (13.9) 30 (18.1) 71 (21.4)
    Retired 44 (26.5) 40 (24.1) 94 (28.3)
    Missing data 2 (1.2) 1 (0.6) –
Note: DBMA = Disease Burden Morbidity Assessment, PRECISE = Program of Research on the Evolution of a 
Cohort Investigating Health System Effects, SD = standard deviation.
*Unless otherwise specified.
†Control group used in the controlled before-and-after design.
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Before-and-after design
A summary including the results for all variables of the before-
and-after design for participants from the intervention group is 
shown in Table 4. The analysis included only those participants 
with data at baseline, after 3 months and after 1 year. After 
3 months, changes in all domains of the heiQ were significantly 
different from baseline, with an effect size ranging from small 
to medium (between 0.20 and 0.52). After 1 year, changes con-
tinued to be significantly different from baseline except for the 
health service navigation domain. Figure 3 shows the changes 
in each domain of the heiQ over one year. The percentage of 
patients in the Intervention group who improved in different 
domains was between 16% (23/143) and 36% (50/140).
Controlled before-and-after design
We matched the 332 participants in this study with 332 par-
ticpants in the PRECISE (control cohort, group C) study by 
age, sex, number of chronic diseases, main diagnosis and other 
diagnoses when possible. Demographic and clinical character-
istics of group C and PR1MaC participants at baseline are 
shown in Table 1. Results over 1 year, with significant differ-
ences in the Physical Component Summary and BMI that 
favour the intervention, are shown in Table 5.
Interpretation
As part of the intervention in this study, we adapted and imple-
mented the integration of disease prevention and management 
services into primary health care for 4 chronic conditions and 
their risk factors. After 3 months, the intervention showed some 
benefit in 6 out of the 8 domains of self-management measured 
by the heiQ, both in terms of absolute mean values and RR 
analysis, compared with the control group. However, the per-
centage of patients in the intervention group who improved in 
different domains varied between 16% and 36% (i.e., they were 
not the majority in any domain). Our interpretation of this is 
that there is still room for improvement and making the inter-
vention more effective. Recently, Coventry and colleagues45 
published the results of a cluster randomized controlled trial for 
patients with depression and comorbid diabetes or cardiovascu-
lar disease in which the heiQ was used as a secondary outcome. 
As in our study, Coventry and colleagues did not observe signifi-
cant improvement in the domains of positive and active engage-
ment in life, and social integration and support.
The evaluation of secondary outcomes in our study also 
showed modest but beneficial effects of the intervention in 
fruit and vegetable consumption, physical activity and the 
physical component of quality of life. In general, after 1 year, 
improvements were still present. BMI showed a modest but 
significant improvement after 1  year. Psychological distress 
did not change. This lack of change could reflect either that 
the length of the interventions was too short or that the ele-
ments behind this situation were not among those targeted by 
the intervention. The prevalence of recommended physical 
activity significantly improved at 3 months but decreased over 
1 year to a level equivalent to baseline. This may indicate a 
Table 2: Participant scores at baseline and after 3 months for the heiQ, by self-management domain
Domain (heiQ) Group
At baseline After 3 mo Mean difference, baseline v. 3 mo (95% CI)  
Cohen’s 
d p‡n Mean ± SD n Mean ± SD Within group* Between group†
Health-directed 
behaviour
Intervention 162 2.61 ± 0.73 153 2.96 ± 0.63 0.32 (0.21 to 0.43) 0.20 (0.08 to 0.32) 0.27 0.001
Control 163 2.66 ± 0.78 156 2.78 ± 0.72 0.11 (0.03 to 0.21)
Positive and active 
engagement in life
Intervention 165 3.10 ± 0.54 156 3.24 ± 0.51 0.13 (0.06 to 0.20) 0.04 (–0.04 to 0.12) 0.12 0.319
Control 165 3.10 ± 0.54 158 3.18 ± 0.50 0.10 (0.04 to 0.15)
Emotional well-being Intervention 160 2.68 ± 0.64 149 2.96 ± 0.60 0.27 (0.18 to 0.36) 0.13 (0.03 to 0.23) 0.19 0.012
Control 160 2.73 ± 0.63 153 2.85 ± 0.56 0.13 (0.06 to 0.19)
Self-monitoring and 
insight
Intervention 159 3.03 ± 0.41 149 3.23 ± 0.38 0.18 (0.11 to 0.25) 0.14 (0.06 to 0.22) 0.39 0.001
Control 160 3.01 ± 0.41 154 3.07 ± 0.44 0.06 (0.01 to 0.11)
Constructive attitudes 
and approaches
Intervention 163 3.07 ± 0.48 153 3.22 ± 0.47 0.15 (0.08 to 0.22) 0.09 (0.01 to 0.18) 0.11 0.035
Control 161 3.13 ± 0.46 155 3.17 ± 0.48 0.03 (–0.02 to 0.09)
Skill and technique 
acquisition
Intervention 163 2.83 ± 0.51 153 3.09 ± 0.45 0.25 (0.17 to 0.32) 0.14 (0.06 to 0.23) 0.31 0.001
Control 161 2.86 ± 0.50 156 2.95 ± 0.45 0.10 (0.04 to 0.17)
Social integration and 
support
Intervention 164 2.98 ± 0.53 154 3.09 ± 0.54 0.10 (0.04 to 0.17) 0.07 (–0.01 to 0.16) 0.19 0.089
Control 161 2.95 ± 0.54 156 2.99 ± 0.53 0.05 (–0.02 to 0.11)
Health service 
navigation
Intervention 165 3.27 ± 0.41 154 3.38 ± 0.42 0.10 (0.03 to 0.18) 0.12 (0.03 to 0.20) 0.35 0.005
Control 166 3.26 ± 0.42 160 3.23 ± 0.45 –0.003 (–0.06 to 0.06)
Note:  ANCOVA = analysis of covariance, heiQ = Health Education Impact Questionnaire, SD = standard deviation.
*Mean difference = mean score at 3 mo – mean score at baseline. 
†Mean difference = adjusted mean after 3 mo (intervention) – adjusted mean after 3 mo (control).
‡ANCOVA was used to compare scores after 3 mo, adjusted for baseline.
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need to reinforce the message at follow-up. A recent system-
atic review and meta-analysis reported that interventions to 
promote physical activity lead to improvements in physical 
activity at 12 months.46 Longer sustainability was unclear.46
The score for self-efficacy for managing chronic disease 
showed no significant difference between intervention and 
control groups. A closer look at the results of this variable 
showed that mean values were high at baseline in both 
groups, with little room for improvement. The statistically 
significant improvement observed in the physical component 
of quality of life of the experimental group was of limited 
clinical importance.47
Other studies of multidisciplinary specialized professionals 
have been conducted in the context of single conditions, includ-
0 1 2 3 4 5 6
RR (95% CI)
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Figure 2: Relative risks (RRs) (intervention group v. control group) and 95% confidence intervals (CIs) of a reliable improvement at 3 
months compared with baseline, by domain of self-management. Values greater than 1.0 indicate more patients in the intervention group 
had reliable improvement in a domain of self-management compared with the control group. The difference between the 2 groups is sig-
nificant when the value of no difference (RR = 1.0) is not included in the CI.
Table 3: Logistic regression analysis for categorical variables at 3 mo, adjusted for baseline
Variable Group
No. of participants at 
baseline/total no. of 
participants (%)
No. of participants 
after 3 mo/total no. 
of participants (%)
Adjusted OR 
(95% CI)
Psy. distress Intervention 16/154 (10.4) 8/154 (5.2) 0.84 (0.29 to 2.45)
Control 15/161 (9.3) 9/158 (5.7)
Fruit and veg. Intervention 49/155 (31.6) 83/151 (55.0) 2.36 (1.41 to 3.95)
Control 50/161 (31.1) 61/160 (38.1)
Phys. activity Intervention 15/155 (9.7) 32/154 (20.8) 3.81 (1.65 to 8.76)
Control 22/161 (13.7) 18/159 (11.3)
Note: CI = confidence interval, Fruit and veg. = recommended fruit and vegetable consumption, OR = odds ratio,  
Phys. activity = recommended physical activity, Psy. distress = presence of psychological distress.
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Table 4: Intervention group results for before-and-after design portion of the PR1MaC study at baseline, after 3 mo and after 
12 mo, by variable; and relative risk, by variable
Variable*
Mean ± SD Baseline v. 3 mo Baseline v. 12 mo
At baseline After 3 mo After 12 mo
Mean difference 
(95% CI)† 
Cohen’s 
d p
Mean difference 
(95% CI)‡ 
Cohen’s 
d p
Health directed 
behaviour, 
n = 140
2.62 ± 0.75 2.96 ± 0.64 2.93 ± 0.64 0.36 
(0.24 to 0.47) 
0.49 < 0.001 0.32 
(0.20 to 0.45) 
0.45 < 0.001
Positive and 
active 
engagement in 
life, n = 142
3.12 ± 0.53 3.25 ± 0.51 3.29 ± 0.49 0.15 
(0.07 to 0.23) 
0.25 < 0.001 0.16 
(0.08 to 0.24) 
0.33 < 0.001
Emotional 
well-being, 
n = 138
2.69 ± 0.65 2.95 ± 0.60 2.98 ± 0.64 0.26 
(0.16 to 0.37) 
0.42 < 0.001 0.30 
(0.18 to 0.40) 
0.45 < 0.001
Self-monitoring 
and insight, 
n = 137
3.06 ± 0.41 3.24 ± 0.37 3.26 ± 0.37 0.18 
(0.10 to 0.28) 
0.46 < 0.001 0.21 
(0.13 to 0.28) 
0.51 < 0.001
Constructive 
attitudes and 
approaches, 
n = 142
3.09 ± 0.47 3.24 ± 0.46 3.27 ± 0.47 0.15 
(0.06 to 0.24) 
0.32 < 0.001 0.17 
(0.08 to 0.26) 
0.38 < 0.001
Skill and 
technique 
acquisition, 
n = 141
2.85 ± 0.50 3.09 ± 0.43 3.12 ± 0.48 0.26 
(0.18 to 0.35) 
0.52 < 0.001 0.29 
(0.20 to 0.38) 
0.55 < 0.001
Social 
integration and 
support, 
n = 142
2.98 ± 0.54 3.09 ± 0.54 3.13 ± 0.56 0.11 
(0.03 to 0.18) 
0.20 0.003 0.13 
(0.06 to 0.21) 
0.27 < 0.001
Health service 
navigation, 
n = 143
3.28 ± 0.41 3.39 ± 0.42 3.35 ± 0.44 0.11 
(0.02 to 0.18) 
0.27 0.006 0.06 
(–0.02 to 0.14) 
0.17 0.104
Score SEM-CD, 
n = 136
7.41 ± 1.82 7.94 ± 1.57 7.76 ± 1.94 0.53 
(0.25 to 0.80) 
0.31 < 0.001 0.55 
(0.26 to 0.84) 
0.19 0.02
PCS, n = 143 42.4 ± 9.8 45.8 ± 9.3 46.7 ± 9.8 3.5 
(2.2 to 4.8) 
0.36 < 0.001 4.2 
(2.7 to 5.6) 
0.44 < 0.001
MCS, n = 143 46.8 ± 10.9 49.5 ± 10.1 49.4 ± 10.2 2.7 
(1.4 to 4.2) 
0.26 < 0.001 2.9 
(1.2 to 4.7) 
0.25 0.002
SF-6D, n = 140 0.661 ± 0.108 0.698 ± 0.113 0.704 ± 0.106 0.040 
(0.022 to 0.059) 
0.34 < 0.001 0.045 
(0.025 to 0.066) 
0.40 < 0.001
BMI, n = 132 31.6 ± 6.7 31.3 ± 7.5 30.6 ± 6.8 –0.27
 (–0.89 to 0.66) 
–0.04 0.5 –0.94 
(–1.48 to –0.46) 
–0.15 < 0.001
Variable No. of participants (%) RR (95% CI) RR (95% CI)
Psy. distress, 
n = 140
15 (10.7) 8 (5.7) 12 (8.6) 0.53 (0.23 to 1.22) 0.80 (0.39 to 1.65)
Fruit and veg., 
n = 140
48 (34.3) 79 (56.4) 70 (50.0) 1.65 (1.25 to 2.16) 1.46 (1.10 to 1.94)
Phys. activity, 
n = 143
14 (9.8) 30 (21.0) 23 (16.1) 2.14 (1.19 to 3.87) 1.64 (0.88 to 3.06)
Note: BMI = body mass index (kg/m2), Fruit and veg. = Recommended fruit and vegetable consumption, MCS = Mental Component Summary of SF-12 (version 2), PA = 
Recommended physical activity, PCS = Physical Component Summary of SF-12 (version 2), PR1MaC = Adaptation, implantation et évaluation d’une intervention 
d’intégration des services de réadaptation en maladies chroniques aux soins de 1re ligne (Adapting and integrating chronic disease prevention and man and management 
services into primary care settings), Psy. Distress = Presence of psychological distress, RR = relative risk, SEM-CD = Self-Efficacy for Managing Chronic Disease, SF-6D = 
Single Index of SF-12, SF-12 (version 2) = 12-Item Short-Form Health Survey, SD = standard deviation.
*Student paired t test used for continuous variables, and McNemar’s test used for categorical variables (calculated only for participants who had completed all 3 
measurements).
†Mean difference = mean after 3 mo – mean at baseline. 
‡Mean difference = mean after 12 mo – mean at baseline.
¶Baseline was the reference in the calculations of RR.
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Figure 3: Distribution of changes (improvement or no improvement) in the intervention group after 1 year compared with baseline, by domain of 
self-management. Values inside the bars show absolute numbers of patients.
Table 5: Controlled before-and-after design: comparison at 1 year
Variable
PR1MaC
(intervention + control) PRECISE (control cohort)
Mean difference (95% CI) Mean ± SD Mean ± SD
At baseline After 12 mo At baseline After 12 mo PR1MaC* PRECISE*
PR1MaC v. 
PRECISE† p‡
PCS 43.6 ± 10.3 45.6 ± 9.7 43.6 ± 11.7 43.8 ± 11.3 2.2 
(1.3 to 3.1)
0.3 
(–0.6 to 1.2)
1.51 
(0.41 to 2.62)
0.007
MCS 47.1 ± 10.8 49.6 ± 9.6 47.2 ± 10.6 48.9 ± 10.3 2.0 
(1.0 to 3.1)
1.6 
(0.6 to 2.5)
0.62 
(–0.54 to 1.77)
0.295
BMI 31.8 ± 7.2 30.7 ± 7.0 30.6 ± 6.1 30.6 ± 6.3 –0.8 
(–1.2 to –0.4)
0.1 
(–0.2 to 0.3)
–0.83 
(–1.29 to –0.37)
< 0.001
Variable
No. of participants/total no. 
of participants (%)
No. of participants/total 
no. of participants (%) OR (95% CI) p
Psy. distress 34/330 
(10.3)
17/315 
(5.4)
40/333 
(12.0)
31/330 
(9.4)
0.56 (0.29 to 1.10) 0.094
Fruit and veg. 103/332 
(31.0)
127/280 
(45.4)
147/325 
(45.2)
177/316 
(56.0)
0.79 (0.55 to 1.13) 0.198
Phys. activity 39/330 
(11.8)
49/280 
(17.5)
60/330 
(18.2)
56/327 
(17.1)
1.30 (0.81 to 2.08) 0.276
Note: ANCOVA = analysis of covariance, BMI = body mass index (kg/m2), CI = confidence interval, Fruit and veg. = recommended fruit and vegetable consumption, MCS = 
mental component cummary of SF-12 (version 2), OR = odds ratio, PCS = Physical Component Summary of SF-12 (version 2), Phys. activity = recommended physical 
activity, PRECISE = Program of Research on the Evolution of a Cohort Investigating Health System Effects, PR1MaC = Adaptation, implantation et évaluation d’une 
intervention d’intégration des services de réadaptation en maladies chroniques aux soins de 1re ligne (Adapting and integrating chronic disease prevention and man and 
management services into primary care settings), Psy. distress = presence of psychological distress, SF-12 (version 2) = 12-Item Short-Form Health Survey.
*Mean difference = mean score after 3 mo – mean score at baseline.
†Mean difference = adjusted mean after 12 mo (PR1MaC) – adjusted mean after 12 mo (PRECISE).
‡ANCOVA used for continuous variables and logistic regression used for dichotomous variables, and were adjusted for scores at baseline.
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ing COPD and asthma,16,48 metabolic syndrome,49 kidney fail-
ure,20 diabetes,50 blood pressure control51 and people with risk 
factors.52 Interventions were based on different approaches, 
mainly self-management support and patient education. The 
outcomes used varied from study to study and included the use 
of health care services, quality of life, various physiologic indi-
cators and modification of risk factors. All of the studies 
reported positive results in their respective outcomes.
Limitations
The main limitation of the study is the short period for fol-
low-up for the RCT component. With a 3-month interven-
tion to start behaviour change, the challenge was to make it 
sustainable over time. For this reason, follow-up responsibility 
was given to primary care physicians by transferring all infor-
mation to the patients’ medical records at the end of each 
intervention. Generalization of the results may be limited 
given the study eligibility based on selected conditions (type 2 
diabetes, cardiovascular disease, COPD and asthma) or risk 
factors (smoking, obesity, hyperlipidemia, carbohydrate intol-
erance and metabolic syndrome). Other factors, such as cul-
tural context and ethnicity, were not evaluated and could also 
limit generalization. Two additional limitations are no infor-
mation was collected about health literacy, and we could not 
control the self-reported data for this variable.
The use of patient self-report questionnaires for outcomes 
may have introduced some desirability bias, but it is consistent 
with the use of a patient-centred approach. We acknowledge 
that participants could not be blinded to the intervention, and 
desirability bias could explain part of the changes observed in 
the immediate intervention group. In addition, the similar 
results in the triple experimental design suggests that they are 
not a consequence of desirability bias. Finally, one-third of 
the total number of patients referred by primary care provid-
ers to the research team declined to participate in the 
research. We did not collect information from these patients. 
We do not know what impact of this had on the composition 
of the sample of participants.
Conclusion
The evaluation of an innovative intervention for adapting and 
integrating chronic disease prevention and management ser-
vices, which addressed more than 1 disease or risk factor into 
primary care settings, yielded positive and promising results. 
This type of intervention can be improved, and its introduc-
tion in the routine of primary care practice would help to 
achieve the primary care goal of high-quality care for patients 
with chronic diseases.
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